Puberty and ovarian function in girls with type 1 diabetes mellitus

Hormone Research

Volumn 71, Issue 1, 2009, Pages 12-21

  Codner, Ethel ^a   Cassorla, Fernando ^a  

^a UNIVERSITY OF CHILE   (Chile)

Author keywords

Growth; Hirsutism; Hyperandrogenism; Insulin; Menarche; Ovary; Polycystic ovarian syndrome; Puberty; Thelarche; Type 1 diabetes mellitus; Weight

Indexed keywords

ANDROGEN; GLUCOSE; INSULIN; LUTEINIZING HORMONE; SEX HORMONE BINDING GLOBULIN;

ADOLESCENCE; ADULTHOOD; AMENORRHEA; BODY MASS; DEVELOPMENTAL DISORDER; DEVELOPMENTAL STAGE; FEMALE; GRANULOSA CELL; HAIR GROWTH; HORMONE ACTION; HUMAN; HYPERANDROGENISM; HYPERGLYCEMIA; HYPOGONADISM; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULIN TREATMENT; MENSTRUATION DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OVARY DISEASE; OVARY FUNCTION; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PUBERTY; SHORT SURVEY; THECA CELL; WAIST HIP RATIO;

ADOLESCENT; ANIMALS; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; MENARCHE; OVARY; PUBERTY;

EID: 56749160591     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000173737     Document Type: Short Survey

References (60)

1. Rohrer T, Stierkorb E, Heger S, Karges B, Raile K, Schwab KO, Holl RW: Delayed pubertal onset and development in German children and adolescents with type 1 diabetes: cross-sectional analysis of recent data from the DPV diabetes documentation and quality management system. Eur J Endocrinol 2007;157:647-653.
2. Codner E, Barrera A, Mook-Kanamori D, Bazaes RA, Unanue N, Gaete X, Avila A, Ugarte F, Torrealba I, Perez V, Panteon E, Cassorla F: Ponderal gain, waist-to-hip ratio, and pubertal development in girls with type-1 diabetes mellitus. Pediatr Diabetes 2004;5:182-189.
3. de Beaufort CE, Swift PG, Skinner CT, Aanstoot HJ, Aman J, Cameron F, Martul P, Chiarelli F, Daneman D, Danne T, Dorchy H, Hoey H, Kaprio EA, Kaufman F, Kocova M, Mortensen HB, Njolstad PR, Phillip M, Robertson KJ, Schoenle EJ, Urakami T, Vanelli M: Continuing stability of center differences in pediatric diabetes care: do advances in diabetes treatment improve outcome? The Hvidoere Study Group on Childhood Diabetes. Diabetes Care 2007;30:2245-2250.
4. Bergqvist N: The gonadal function in female diabetics. Acta Endocrinol Suppl (Copenh) 1954;19:1-20.
5. Codner E, Soto N, Lopez P, Trejo L, Avila A, Eyzaguirre FC, Iniguez G, Cassorla F: Diagnostic criteria for polycystic ovary syndrome and ovarian morphology in women with type 1 diabetes mellitus. J Clin Endocrinol Metab 2006;91:2250-2256.
6. Codner E, Escobar-Morreale HF: Hyperandrogenism and polycystic ovary syndrome in women with type 1 diabetes mellitus. J Clin Endocrinol Metab 2007;92:1209-1216.
7. Strotmeyer ES, Steenkiste AR, Foley TP Jr, Berga SL, Dorman JS: Menstrual cycle differences between women with type 1 diabetes and women without diabetes. Diabetes Care 2003;26:1016-1021.
8. Djursing H, Hagen C, Nyboe Andersen A, Svenstrup B, Bennett P, Molsted Pedersen L: Serum sex hormone concentrations in insulin dependent diabetic women with and without amenorrhoea. Clin Endocrinol (Oxf) 1985;23:147-154.
9. Griffin ML, South SA, Yankov VI, Booth RA Jr, Asplin CM, Veldhuis JD, Evans WS: Insulin-dependent diabetes mellitus and menstrual dysfunction. Ann Med 1994;26:331-340.
10. Arrais RF, Dib SA: The hypothalamus-pituitary-ovary axis and type 1 diabetes mellitus: a mini review. Hum Reprod 2006;21:327-337.
11. Djursing H, Andersen AN, Hagen C, Petersen K: Gonadotropin secretion before and during acute and chronic dopamine-receptor blockade in insulin-dependent diabetic patients with amenorrhea. Fertil Steril 1985;44:49-55.
12. Bestetti GE, Junker U, Locatelli V, Rossi GL: Continuous subtherapeutic insulin counteracts hypothalamopituitary-gonadal alterations in diabetic rats. Diabetes 1987;36:1315-1319.
13. Adashi EY, Hsueh AJ, Yen SS: Insulin enhancement of luteinizing hormone and follicle-stimulating hormone release by cultured pituitary cells. Endocrinology 1981;108:1441-1449.
14. Bruning JC, Gautam D, Burks DJ, Gillette J, Schubert M, Orban PC, Klein R, Krone W, Muller-Wieland D, Kahn CR: Role of brain insulin receptor in control of body weight and reproduction. Science 2000;289:2122-2125.
15. Poretsky L, Kalin MF: The gonadotropic function of insulin. Endocr Rev 1987;8:132-141.
16. Poretsky L, Cataldo NA, Rosenwaks Z, Giudice LC: The insulin-related ovarian regulatory system in health and disease. Endocr Rev 1999;20:535-582.
17. Baillargeon JP, Nestler JE: Commentary: polycystic ovary syndrome: a syndrome of ovarian hypersensitivity to insulin? J Clin Endocrinol Metab 2006;91:22-24.
18. Willis D, Mason H, Gilling-Smith C, Franks S: Modulation by insulin of follicle-stimulating hormone and luteinizing hormone actions in human granulosa cells of normal and polycystic ovaries. J Clin Endocrinol Metab 1996;81:302-309.
19. Hsueh AJ, Billig H, Tsafriri A: Ovarian follicle atresia: a hormonally controlled apoptotic process. Endocr Rev 1994;15:707-724.
20. Kezele PR, Nilsson EE, Skinner MK: Insulin but not insulin-like growth factor-1 promotes the primordial to primary follicle transition. Mol Cell Endocrinol 2002;192:37-43.
21. Codner E, Iniguez G, Villarroel C, Lopez P, Soto N, Sir-Petermann T, Cassorla F, Rey RA: Hormonal profile in women with polycystic ovarian syndrome with or without type 1 diabetes mellitus. J Clin Endocrinol Metab 2007;92:4742-4746.
22. Chang AS, Dale AN, Moley KH: Maternal diabetes adversely affects preovulatory oocyte maturation, development, and granulosa cell apoptosis. Endocrinology 2005;146:2445-2453.
23. Colton SA, Pieper GM, Downs SM: Altered meiotic regulation in oocytes from diabetic mice. Biol Reprod 2002;67:220-231.
24. Polonsky KS, Given BD, Hirsch L, Shapiro ET, Tillil H, Beebe C, Galloway JA, Frank BH, Karrison T, Van Cauter E: Quantitative study of insulin secretion and clearance in normal and obese subjects. J Clin Invest 1988;81:435-441.
25. Szadkowska A, Pietrzak I, Mianowska B, Bodalska-Lipinska J, Keenan HA, Toporowska-Kowalska E, Mlynarski W, Bodalski J: Insulin sensitivity in type 1 diabetic children and adolescents. Diabet Med 2008;25:282-288.
26. Poretsky L, Clemons J, Bogovich K: Hyperinsulinemia and human chorionic gonadotropin synergistically promote the growth of ovarian follicular cysts in rats. Metabolism 1992;41:903-910.
27. Du Caju MV, Rooman RP, op de Beeck L: Longitudinal data on growth and final height in diabetic children. Pediatr Res 1995;38:607-611.
28. Ahmed ML, Connors MH, Drayer NM, Jones JS, Dunger DB: Pubertal growth in IDDM is determined by HbA1c levels, sex, and bone age. Diabetes Care 1998;21:831-835.
29. Clarson C, Daneman D, Ehrlich RM: The relationship of metabolic control to growth and pubertal development in children with insulin-dependent diabetes. Diabetes Res 1985;2:237-241.
30. Parent AS, Teilmann G, Juul A, Skakkebaek NE, Toppari J, Bourguignon JP: The timing of normal puberty and the age limits of sexual precocity: variations around the world, secular trends, and changes after migration. Endocr Rev 2003;24:668-693.
31. Danielson KK, Palta M, Allen C, D'Alessio DJ: The association of increased total glycosylated hemoglobin levels with delayed age at menarche in young women with type 1 diabetes. J Clin Endocrinol Metab 2005;90:6466-6471.
32. Picardi A, Cipponeri E, Bizzarri C, Fallucca S, Guglielmi C, Pozzilli P: Menarche in type 1 diabetes is still delayed despite good metabolic control. Fertil Steril doi:10.1016/j.fertnstert.2007.09.035 2008.
33. Lombardo F, Zalzano G, Crisafulli G, Valenzise M, Zirilli G, Manzo V, Aversa T, De Luca F: Menarcheal timing in intensively treated girls with type 1 diabetes mellitus. Nutr Metab Cardiovasc Dis. doi:10.1016/j.numecd.2007.12.002 2008, in press.
34. Elamin A, Hussein O, Tuvemo T: Growth, puberty, and final height in children with Type 1 diabetes. J Diabetes Complications 2006;20:252-256.
35. Kjaer K, Hagen C, Sando SH, Eshoj O: Epidemiology of menarche and menstrual disturbances in an unselected group of women with insulin-dependent diabetes mellitus compared to controls. J Clin Endocrinol Metab 1992;75:524-529.
36. Yeshaya A, Orvieto R, Dicker D, Karp M, Ben-Rafael Z: Menstrual characteristics of women suffering from insulin-dependent diabetes mellitus. Int J Fertil Menopausal Stud 1995;40:269-273.
37. Adcock CJ, Perry LA, Lindsell DR, Taylor AM, Holly JM, Jones J, Dunger DB: Menstrual irregularities are more common in adolescents with type 1 diabetes: association with poor glycaemic control and weight gain. Diabet Med 1994;11:465-470.
38. Dunger DB, Ahmed ML, Ong KK: Early and late weight gain and the timing of puberty. Mol Cell Endocrinol 2006;254-255:140-145.
39. Snell-Bergeon JK, Dabelea D, Ogden LG, Hokanson JE, Kinney GL, Ehrlich J, Rewers M: Reproductive history and hormonal birth control use are associated with coronary calcium progression in women with type 1 diabetes mellitus. J Clin Endocrinol Metab 2008;93:2142-2148.
40. Schroeder B, Hertweck SP, Sanfilippo JS, Foster MB: Correlation between glycemic control and menstruation in diabetic adolescents. J Reprod Med 2000;45:1-5.
41. Eyzaguirre FC, Iñiguez G, P L, Avila A, Torrealba I, Giadrosich V, Pérez-Bravo F, Cassorla F, Codner E: Frequency of ovulatory cycles in young adolescents with type 1 diabetes mellitus. Horm Res 2007;68:9.
42. Sherman LS, Rogers DG, Gabbay KH: Pulsatility of luteinizing hormone during puberty is dependent on recent glycemic control. Adolesc Paediatr Gynecol 1991;4:87-92.
43. Codner E, Mook-Kanamori D, Bazaes RA, Unanue N, Sovino H, Ugarte F, Avila A, Iniguez G, Cassorla F: Ovarian function during puberty in girls with type 1 diabetes mellitus: response to leuprolide. J Clin Endocrinol Metab 2005;90:3939-3945.
44. Meyer K, Deutscher J, Anil M, Berthold A, Bartsch M, Kiess W: Serum androgen levels in adolescents with type 1 diabetes: relationship to pubertal stage and metabolic control. J Endocrinol Invest 2000;23:362-368.
45. Daneman D, Rodin G, Jones J, Colton P, Rydall A, Maharaj S, Olmsted M: Eating disorders in adolescent girls and young adult women with type 1 diabetes. Diabetes Spectr 2002;15:83-105.
46. Martinez-Aguayo A, Araneda JC, Fernandez D, Gleisner A, Perez V, Codner E: Tobacco, alcohol, and illicit drug use in adolescents with diabetes mellitus. Pediatr Diabetes 2007;8:265-271.
47. Escobar-Morreale HF, Roldan B, Barrio R, Alonso M, Sancho J, de la Calle H, Garcia-Robles R: High prevalence of the polycystic ovary syndrome and hirsutism in women with type 1 diabetes mellitus. J Clin Endocrinol Metab 2000;85:4182-4187.
48. Roldan B, Escobar-Morreale HF, Barrio R, de la Calle H, Alonso M, Garcia-Robles R, Sancho J: Identification of the source of androgen excess in hyperandrogenic type 1 diabetic patients. Diabetes Care 2001;24:1297-1299.
49. Amin R, Schultz C, Ong K, Frystyk J, Dalton RN, Perry L, Orskov H, Dunger DB: Low IGF-I and elevated testosterone during puberty in subjects with type 1 diabetes developing microalbuminuria in comparison to normoalbuminuric control subjects: the Oxford Regional Prospective Study. Diabetes Care 2003;26:1456-1461.
50. Haffner SM, Klein R, Dunn JF, Moss SE, Klein BE: Increased testosterone in type I diabetic subjects with severe retinopathy. Ophthalmology 1990;97:1270-1274.
51. Virdis R, Zampolli M, Street ME, Vanelli M, Potau N, Terzi C, Ghizzoni L, Ibanez L: Ovarian 17-alpha-hydroxyprogesterone responses to GnRH analog testing in oligomenorrheic insulin-dependent diabetic adolescents. Eur J Endocrinol 1997;136:624-629.
52. Remer T, Maser-Gluth C, Boye KR, Hartmann MF, Heinze E, Wudy SA: Exaggerated adrenarche and altered cortisol metabolism in type 1 diabetic children. Steroids 2006;71:591-598.
53. Dunger DB, Acerini CL: IGF-I and diabetes in adolescence. Diabetes Metab 1998;24:101-107.
54. Bryden KS, Peveler RC, Stein A, Neil A, Mayou RA, Dunger DB: Clinical and psychological course of diabetes from adolescence to young adulthood: a longitudinal cohort study. Diabetes Care 2001;24:1536-1540.
55. Schultz CJ, Konopelska-Bahu T, Dalton RN, Carroll TA, Stratton I, Gale EA, Neil A, Dunger DB: Microalbuminuria prevalence varies with age, sex, and puberty in children with type 1 diabetes followed from diagnosis in a longitudinal study. Oxford Regional Prospective Study Group. Diabetes Care 1999;22:495-502.
56. Ahmed ML, Ong KK, Watts AP, Morrell DJ, Preece MA, Dunger DB: Elevated leptin levels are associated with excess gains in fat mass in girls, but not boys, with type 1 diabetes: longitudinal study during adolescence. J Clin Endocrinol Metab 2001;86:1188-1193.
57. Iñiguez G, Torrealba IM, Avila A, Cassorla F, Codner E: Adiponectin serum levels and their relationships to androgen concentrations and ovarian volume during puberty in girls with type 1 diabetes mellitus. Horm Res 2008;70:112-117.
58. Salerno M, Argenziano A, Di Maio S, Gasparini N, Formicola S, De Filippo G, Tenore A: Pubertal growth, sexual maturation, and final height in children with IDDM: effects of age at onset and metabolic control. Diabetes Care 1997;20:721-724.
59. Donaghue KC, Fairchild JM, Craig ME, Chan AK, Hing S, Cutler LR, Howard NJ, Silink M: Do all prepubertal years of diabetes duration contribute equally to diabetes complications? Diabetes Care 2003;26:1224-1229.
60. Schriock EA, Winter RJ, Traisman HS: Diabetes mellitus and its effects on menarche. J Adolesc Health Care 1984;5:101-104.